ストックスクリーナーアプリを入手
83.68
0.77%
0.64
アフターアワーズ：
83.68
Edwards Lifesciences Corp (EW) 最新ニュース
UBS initiates Edwards Lifesciences stock coverage with buy rating By Investing.com - Investing.com Canada
Form 4 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com Nigeria
Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares - Investing.com
Form 144 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com South Africa
Form 144 Edwards Lifesciences Corp For: 27 July - Investing.com India
EW|Edwards Lifesciences Corp|Price:83.040|Chg%:+0.410 - TradingKey
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion? - Yahoo Finance Singapore
Edwards Lifesciences (EW) insider Zovighian details recent $2.83M stock sale in Form 144 - Stock Titan
Edwards Lifesciences Corp (EW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edwards Lifesciences stock trades steady as TAVR growth supports margins - Ad-hoc-news.de
ETFs Investing in Edwards Lifesciences Corporation Stocks - TradingView
Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium - Yahoo Finance
Edwards Lifesciences Corp (EW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Edwards Lifesciences Corp (EW) Institutional Confidence - TradingKey
EW|Edwards Lifesciences Corp|Price:82.630|Chg%:-1.185 - TradingKey
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion - MedTech Dive
Why is Edwards Lifesciences stock rallying today? By Investing.com - Investing.com South Africa
Why is Edwards Lifesciences stock rallying today? - Investing.com
Bernstein raises Edwards Lifesciences stock price target on earnings beat - Investing.com
Bernstein raises Edwards Lifesciences stock price target on earnings beat By Investing.com - Investing.com Canada
Edwards Lifesciences (EW) Receives Upgrade from Leerink with New Price Target - GuruFocus
Edwards Lifesciences Reports Strong Q2 2026 Results With 13.6% Sales Growth, Raises Full-Year Guidance - Minichart
Piper Sandler raises Edwards Lifesciences stock price target on earnings beat - Investing.com
Edwards lifts FY26 growth outlook following steady Q2 performance - Yahoo Finance
Edwards Lifesciences Corporatio (EW) Stock Forecasts - Yahoo Finance
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Life - Benzinga
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises - Yahoo Finance
EDWARDS LIFESCIENCES CORP : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $101 FROM $87 - Bitget
Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Bernstein Adjusts Price Target on Edwards Lifesciences to $99 From $96, Maintains Market Perform Rating - marketscreener.com
Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum - Investing.com
Edwards Lifesciences stock holds focus on margin and growth - AD HOC NEWS
Leerink upgrades Edwards Lifesciences stock rating on TAVR momentum By Investing.com - Investing.com Canada
Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87 - marketscreener.com
EW|Edwards Lifesciences Corp|Price:83.800|Chg%:-0.570 - TradingKey
Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo! Finance Canada
Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and Strategic Advancements - GuruFocus
Edwards Lifesciences Announces Q2 2026 Financial Results Highlighting Market Leadership - Kalkine Media
Edwards Lifesciences (EW) Reports Strong Q2 2026 Sales Growth - GuruFocus
Edwards Lifesciences Q2 Earnings Call Highlights - Yahoo Finance
Edwards Lifesciences earnings up next: TAVR momentum in focus - Investing.com UK
Earnings call transcript: Edwards Lifesciences tops Q2 2026 estimates, lifts sales outlook - Investing.com
Edwards Lifesciences (EW) Reports Strong Q2 Earnings, Raises Rev - GuruFocus
Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Edwards Lifesciences Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Edwards Lifesciences Jumps After Strong Q2 Growth and Higher 2026 Sales Outlook - Moomoo
Edwards Lifesciences jumps after strong Q2 growth and higher 2026 sales outlook - Quiver Quantitative
Edwards Lifesciences Narrows Full-Year Sales Outlook After Second-Quarter Growth - WSJ
Is Edwards Lifesciences (EW) Undervalued After Q2 Earnings Beat? - GuruFocus
Edwards Lifesciences Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Set - marketscreener.com
Edwards Lifesciences soars 6% on strong Q2 results, raised sales guidance - Investing.com
Edwards Lifesciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada
EDWARDS LIFESCIENCES ($EW) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Edwards Lifesciences Reports Second Quarter Results - Yahoo Finance
Edwards Lifesciences earnings up next: TAVR momentum in focus By Investing.com - Investing.com South Africa
Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ... By GuruFocus - Investing.com Canada
US28176EAD0 Bond Profile — Key Metrics - TradingView
Edwards Lifesciences stock trades steady as transcatheter heart valve revenue grows - AD HOC NEWS
Lobbying Update: $280,000 of EDWARDS LIFESCIENCES LLC lobbying was just disclosed - Quiver Quantitative
Edwards Lifesciences stock advances on earnings and guidance - Ad-hoc-news.de
TD Cowen reiterates Edwards Lifesciences stock Buy rating on TAVR growth - Investing.com
4.89%
大文字化:
|
ボリューム (24 時間):